Menquadfi vial 0.5ML
Ended Awarded Last action
- Contract number
- SPE2DR26F8LKF
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $2,393
Award facts
- Contract value 100% obligated
- $2,392.65 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $2,392.65 firm fixed-price delivery order to AmerisourceBergen Drug Corp on January 16, 2026, for the supply of Menquadfi vial (0.5mL), a meningococcal conjugate vaccine. This non-set-aside contract is expected to be completed by January 20, 2026, with performance taking place at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a routine pharmaceutical procurement under the Defense Logistics Agency's medical supply chain operations, supporting federal healthcare requirements.
This award is issued as a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (contract vehicle SPE2DX), valued at $999,999,999.00 through December 2026. AmerisourceBergen, a subsidiary of parent company Cencora, Inc., is a major pharmaceutical distributor serving military healthcare systems and other federal agencies through this comprehensive global pharmaceutical support vehicle. The parent company also maintains a separate IDC with the Defense Logistics Agency valued up to $999,999,999.00 extending through December 2031, underscoring the critical role both entities play in supplying essential medications, vaccines, medical devices, and specialized healthcare commodities to support Department of Defense and military treatment facilities worldwide.
Quick answers
Who was awarded contract SPE2DR26F8LKF?
SPE2DR26F8LKF was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 16, 2026.
How much is contract SPE2DR26F8LKF worth?
The government has obligated $2,393 on SPE2DR26F8LKF.
Is contract SPE2DR26F8LKF an order under another contract?
Yes. SPE2DR26F8LKF is a delivery order under SPE2DR25D7905, an indefinite delivery contract.
Was contract SPE2DR26F8LKF competed?
The extent of competition for SPE2DR26F8LKF was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award